EC - Horizon 2020 logo

DEVELOPMENT OF IMMUNE TOLERANCE THERAPIES FOR THE TREATMENT OF RHEUMATIC DISEASES
Deadline: 10 Jan 2017   CALL EXPIRED

EU logo mono EC - Horizon 2020

 Health Care
 Pharmaceuticals
 Medical equipment
 Medical Biotechnology
 Horizon2020
 Research

Topic Description
Specific Challenge:

Autoimmune diseases affect approximately 5% of the population of Europe, with two-thirds of the patients being female.

Scope:

Development of a translational research project for the induction and monitoring of immune tolerance in Rheumatic Diseases: Rheumatoid Arthritis (RA).

Expected Impact:

If successful, immune tolerance approaches would revolutionize treatment of RA by inducing drug-free remission. Coupled with diagnostic tests, screening initiatives for “at-risk” individuals, it may stop the disease before joint damage can occur. For healthy but at-risk patient, this would offer a screening and “vaccination” for the prevention of RA.



Public link:   Only for registered users


Up2Europe Ads